Quentis Therapeutics quentistx.com


Public lists: Cancer Therapeutics (1133)

Quentis Therapeutics is a preclinical stage biotechnology company that is translating novel biology into new therapeutic approaches to help more cancer patients benefit from immunotherapy. Based on deep expertise in endoplasmic reticulum (ER) stress biology and the tumor microenvironment, the company is pioneering first-in-class ER stress response modulators to boost the immune system's ability to fight cancer. The company's lead program is a first-in-class IRE1α inhibitor. Quentis is pursuing ...Show all

Quentis Therapeutics is a preclinical stage biotechnology company that is translating novel biology into new therapeutic approaches to help more cancer patients benefit from immunotherapy. Based on deep expertise in endoplasmic reticulum (ER) stress ...Show all

Company (Alive / Active)

Phone: 646-440-9249

Fax:

430 E 29th St
Suite 1005
New York, 10016
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Quentis Therapeutics $51M Feb 27, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Quentis Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Empire State DevelopmentGovernmentNew York, New York, United StatesSeries A
Polaris PartnersVenture CapitalBoston, Massachusetts, United StatesSeries A
AbbVie Biotech VenturesCorporate VentureLake Forest, Illinois, United StatesSeries A
New York VenturesVenture CapitalNew York, New York, United StatesSeries A
Alexandria Venture InvestmentsCorporate VenturePasadena, California, United StatesSeries A
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)